Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1379, 2011-01, pp. : 27-28
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Natalizumab: HSV2 infection, PML and IRIS: case report
Reactions Weekly, Vol. 1, Iss. 1381, 2011-01 ,pp. :
Access to resources
Recommend
Natalizumab: First reports of sarcoidosis: 2 case reports
Reactions Weekly, Vol. 1, Iss. 1388, 2012-01 ,pp. :
Natalizumab: First report of allergy: 2 case reports
Reactions Weekly, Vol. 1, Iss. 1132, 2006-01 ,pp. :
Natalizumab: Severe haematological complications: 2 case reports
Reactions Weekly, Vol. 1, Iss. 1327, 2010-01 ,pp. :
Natalizumab: First report of malignant melanoma: 2 case reports
Reactions Weekly, Vol. 1, Iss. 1189, 2008-01 ,pp. :